[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601383":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":36,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":10,"overallStatus":58,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Minia University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"ESRD patients",null,"100 patients on maintainance hemodialysis",{"label":13,"type":10,"description":14,"interventionNames":10},"Control groub","50 Healthy individuals",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Kerolles Adel Estawrow Saleh, MBChB","CONTACT","01227657867","Kerolesadel1997@gmail.com",[22],{"facility":23,"status":10,"city":24,"state":10,"zip":10,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Nephrology and urology hospital, Minia unersity hospital, Faculty of medicine, Minia university","Minya","Egypt","EG",{"type":28,"coordinates":29},"Point",[30,31],30.75813,28.09193,{"lat":31,"lon":30},[34],{"name":35,"role":18,"phone":10,"phoneExt":10,"email":10},"Shima Hassan Hamdy, MD of Internal medicine",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Kerolles Adel Estawrow Saleh","Resident physician","100601383","copper-to-zinc-ratio-in-end-stage-renal-disease-patients-outcome-100601383",false,"NCT07109778","Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome","Impact of Copper to Zinc Ratio on Outcome of End Stage Renal Disease Patients","Inclusion Criteria:\n\n* ESRD patients including those on maintenance HD\n\nExclusion Criteria:\n\n* Acute kidney injury or rapidly progressive glomerulonephritis, acute infections or active inflammatory conditions as sepsis and autoimmune diseases, liver cirrhosis (Child-Pugh Class B or C), gastrointestinal disorders as inflammatory bowel disease, malabsorption, history of organ transplantation excluding kidney transplantation who may be included in a separate analysis if sufficient numbers are recruited, receiving total parenteral nutrition, Cu or Zn metabolism disorders as Wilson's disease, vitamin complex supplementation or antioxidants within the past 6 months, recent hospitalization within the past 3 months, recent surgery within 3 months, recent blood transfusion \\\u003C 3 months, Pregnancy or lactation, Malignancy.",true,"ALL","18 Years",{"count":51,"type":52},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational clinical trial is to Study the impact of copper to zinc ratio on the outcome of ESRD patients",[56,57],"ESRD (End Stage Renal Disease)","Control Condition","NOT_YET_RECRUITING","2025-07-31",{"date":61,"type":62},"2025-08-07","ACTUAL",{"date":64,"type":52},"2025-08-01",{"date":66,"type":52},"2026-04-01",{"name":5,"class":6},1]